Keshavjee, S <br/><br/>
A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.  [electronic resource] 

 -  The Journal of thoracic and cardiovascular surgery  Feb 2005 
 - 423-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0022-5223 
<br/><br/><label>Standard No.: </label>10.1016/j.jtcvs.2004.06.048  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Biomarkers--blood<br/>Cardiopulmonary Bypass<br/>Complement Inactivator Proteins--antagonists & inhibitors<br/>Complement System Proteins--drug effects<br/>Double-Blind Method<br/>Female<br/>Graft Rejection--etiology<br/>Humans<br/>Length of Stay<br/>Lung Diseases--mortality<br/>Lung Transplantation<br/>Male<br/>Middle Aged<br/>North America<br/>Oxygen Consumption--drug effects<br/>Postoperative Complications--etiology<br/>Receptors, Complement--antagonists & inhibitors<br/>Reperfusion Injury--etiology<br/>Respiration, Artificial<br/>Surgical Wound Infection--etiology<br/>Survival Analysis<br/>Treatment Outcome